Filing Details
- Accession Number:
- 0000899243-22-011246
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-16 16:46:31
- Reporting Period:
- 2022-03-14
- Accepted Time:
- 2022-03-16 16:46:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652908 | A. Douglas Dachille | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-14 | 10,000 | $8.19 | 20,000 | No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
Footnotes
- Represents the weighted average purchase price of the shares purchased from $8.1699 to $8.2084 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions as reported in this footnote.
- These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Billionaire Hedge Funds
